Cells from a Burkitt’s lymphoma which harbor EBV in type I latency had previously been engineered to co-express Green Fluorescent Protein (GFP), Nerve Growth Factor receptor (NGFR) and Zta (BZLF1) from an inducible bi-directional promoter (Akata-Zta). This evidence concerns the gene NGFR and Burkitt lymphoma.